Profile
Russell P.
Pagano worked as the Vice President of Regulatory & Clinical Affairs at BioMimetic Therapeutics, Inc. Prior to that, he was the Chief of Pacing, Defibrillators & Leads Branch at the US Food & Drug Administration from 1994 to 2001.
From 2001 to 2007, he worked as the Executive Vice President at M Squared Associates, Inc. Pagano holds a doctorate degree from Duke University.
Former positions of Russell P. Pagano
| Companies | Position | End |
|---|---|---|
M Squared Associates, Inc.
 M Squared Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Part of KCBN Holding, Inc., M Squared Associates, Inc. is a clinical, regulatory, and quality consulting firm based in New York, NY. The company specializes in providing strategic solutions for complex regulatory challenges to US and international medical technology organizations, ranging from start-ups to multinational device manufacturers. M Squared Associates is a trusted advisor in getting the most groundbreaking technologies from concept to market. The company was founded in 2001 by Marie Marlow, who has been the CEO since then. On March 16, 2022, the company was acquired by ProPharma Group Holdings LLC. | Corporate Officer/Principal | 2007-04-30 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Corporate Officer/Principal | 2001-04-30 |
BioMimetic Therapeutics, Inc.
 BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN. | Chief Tech/Sci/R&D Officer | - |
Training of Russell P. Pagano
| Duke University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
BioMimetic Therapeutics, Inc.
BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN. | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
M Squared Associates, Inc.
M Squared Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Part of KCBN Holding, Inc., M Squared Associates, Inc. is a clinical, regulatory, and quality consulting firm based in New York, NY. The company specializes in providing strategic solutions for complex regulatory challenges to US and international medical technology organizations, ranging from start-ups to multinational device manufacturers. M Squared Associates is a trusted advisor in getting the most groundbreaking technologies from concept to market. The company was founded in 2001 by Marie Marlow, who has been the CEO since then. On March 16, 2022, the company was acquired by ProPharma Group Holdings LLC. | Commercial Services |
- Stock Market
- Insiders
- Russell P. Pagano
